Position in RDNT
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$23,679,472
-$4,394,609 QoQ
Shares Held
423,680
+7.7% QoQ
Ownership
0.539%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 64%
Shared 0%
None 36%
Common Shares in RDNT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026RAYMOND JAMES FINANCIAL INC holds $1,710,810,866 across 26 Diagnostics & Research names. RDNT ranks #16 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
775,318 | $381,092,054 | |
| 2 | DHR |
Danaher Corp /De/
|
1,647,893 | $312,440,511 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
1,202,725 | $205,112,720 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
272,955 | $153,370,681 | |
| 5 | NTRA |
Natera, Inc.
|
591,043 | $118,202,687 | |
| 6 | DGX |
Quest Diagnostics Inc
|
458,455 | $89,848,009 | |
| 7 | A |
Agilent Technologies, Inc.
|
616,428 | $70,260,462 | |
| 8 | MEDP |
Medpace Holdings, Inc.
|
131,373 | $63,083,998 |
All Filings in RDNT
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $23,679,472 | 423,680 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $28,074,081 | 393,470 | Shares | Defined | 2026-02-18 | |
| 2025-09-30 | $33,131,304 | 434,737 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $28,487,493 | 500,571 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $24,517,029 | 493,102 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $33,089,560 | 473,791 | Shares | Defined | 2025-04-23 | |
| No filing history on record for this holder in this stock. | ||||||